The care-gap for women living with heart failure

17 May 2025 (08:00 - 12:45)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Orla Graham

Southern Health and Social Care Trust, Craigavon (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail

Which treatment attributes do patients with transthyretin amyloid cardiomyopathy value most?

Ms A. Carr (Hagersville, CA)

Abstract Slides Video

Presentation thumbnail

Using dapagliflozin to reduce NT-proBNP and improve symptom in transthyretin cardiac amyloidosis - a series of n-of-1 trials pilot study

Doctor E. Haakansson (Umea, SE)

Abstract Slides Video

Presentation thumbnail

Clinical characteristics and outcomes in a cohort of patients starting treatment with vericiguat in the US.

Doctor A. Michel (Basel, CH)

Abstract Slides Video

Presentation thumbnail

Intermittent levosimendan therapy and survival outcomes in advanced heart failure: insights from a real-world single-centre study

Doctor C. Gregorio (Lisbon, PT)

Abstract Slides Video

Presentation thumbnail

Ambulatory blood pressure monitoring reveals true significant hypotension in stable HF patients; Is this an overlooked issue?

Doctor G. Bruno (Limerick, IE)

Abstract Slides Video

Access the full session

Session thumbnail

ePosters in chronic heart failure - pharmacotherapy (2)

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025

You may be interested in

Congress Session

Deeper phenotyping in heart failure: race- and sex-related differences

Congress Session

Addressing gender differences and ethnic disparities in heart failure

Congress Session

Advancing women's cardiovascular health: global strategies and innovations

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources